Pomegra
---
Where the Stock Stands Right Now
CoreWeave, Inc. (NASDAQ: CRWV) closed at $79.86 on March 12, 2026 — down 2.56% on the session with $1.3 billion in trading volume, placing it 78th in overall market activity for the day. The stock traded as low as $78.40 intraday, continuing a prolonged slide from its 50-day moving average of $88.69 and its 200-day moving average of $98.40. The company's market capitalization stands at approximately $33.46 billion. Shares have shed more than half their value from peak levels, drawing intense debate among the 32 analysts currently covering the name.
---
The Earnings Shock That Set the Tone
The origin of CRWV's current pressure traces directly to its Q4 2025 earnings report, released February 26, 2026. On the surface, Q4 revenue of $1.57 billion represented 110.4% year-over-year growth, comfortably ahead of the $1.55 billion consensus. The contracted revenue backlog swelled to $66.8 billion — up more than $11 billion from the prior quarter and more than 4x higher than a year ago — while active power capacity reached 850 megawatts across 43 data centers.
However, the critical fault lines emerged below those headline figures. CoreWeave posted an adjusted loss per share of -$0.89, dramatically missing the -$0.61 analyst consensus. The company's net loss for Q4 came in at $452 million — nearly double what the market had anticipated. Adjusted EBITDA landed at $898 million, below the $929 million expected.
The real shock came from Q1 2026 guidance: $1.9–$2.0 billion in revenue, a substantial miss versus the $2.29 billion Wall Street had modeled. Adjusted operating income for Q1 was guided between $0 and $40 million, signaling a near-complete margin collapse at the start of the year. The stock fell more than 18% in a single session following the announcement — its worst single-day move.
---
The Bull Case: $66.8 Billion in Backlog Is Real
Despite the carnage, the structural bull case for CRWV remains intact according to the majority of covering analysts. The $66.8 billion contracted backlog represents hard customer commitments — not projections — with management confirming all contracts are expected to generate revenue by year-end 2026. The weighted average contract length has extended from four to five years, signaling customers are locking in for the long haul.
New Q4 customers included Midjourney, Cursor, Cognition, and Mercado Libre (MELI), alongside deepened relationships with hyperscale partners. Management provided a full-year 2026 revenue outlook of $12–$13 billion, roughly in line with consensus, and an annualized exit run rate of $17–$19 billion at the end of 2026 — expanding to more than $30 billion by exit 2027. CoreWeave is planning $30–$35 billion in capital expenditures in 2026, with management asserting substantially all of it is tied to already-signed contracts. CEO Mike Intrator framed the margin compression plainly: "Our margins reflect the cost of building tomorrow's revenues."
Customers including Alphabet's (GOOG, GOOGL) Google and OpenAI remain anchors of the platform, providing revenue visibility that the backlog figure alone does not fully capture.
---
The Bear Case: Legal Firestorm and Insider Exodus
The most pressing near-term risk is a rapidly expanding securities litigation front. Multiple law firms — including Bronstein Gewirtz & Grossman, Pomerantz, Hagens Berman, Kessler Topaz, and Berger Montague — have filed or announced class action lawsuits alleging that CoreWeave and its leadership misrepresented the company's capacity to fulfill customer demand and downplayed the risks tied to supplier dependence during the March–December 2025 period. The lead-plaintiff deadline in several of these actions falls on March 13, 2026 — today — amplifying legal uncertainty and headline risk.
The legal backdrop is rooted partly in CoreWeave's operational stumbles. A November 2025 financial disclosure revealed data center construction delays caused by a third-party developer, initially described as isolated. The CEO subsequently acknowledged the issue extended to several data centers managed by the same provider, triggering a 16.3% single-session drop in the stock. The delays were later linked to Core Scientific (CORZ), a company CoreWeave had attempted to acquire in a deal announced in July 2025 — only for Core Scientific shareholders to reject the merger in October 2025, sending CRWV down 6.3% that day alone.
Adding to bearish pressure, insider Brannin McBee disclosed the sale of approximately 500,000 total shares at an average price of $72.61 each in transactions dated March 9, 2026 — a 54.68% reduction in his ownership stake that generated roughly $36.3 million in proceeds. The disclosures, filed with the SEC, triggered the 2.56% session decline on March 12 as investors interpreted the large-scale exit as a negative signal.
---
Analyst Landscape: A Sharply Divided Street
Wall Street's view on CRWV is more polarized than the headline "Moderate Buy" consensus implies. Of the 32 analysts currently covering the stock:
- 18 have Buy or Strong Buy ratings
- 12 have Hold ratings
- 2 have Sell ratings
The consensus 12-month price target stands at $122.35, representing approximately 53% upside from current levels near $79.86. However, recent actions reflect a cautious tone across the board. Barclays cut its target from $120 to $90 and shifted to "equal weight." Truist Financial raised its target modestly from $84 to $85 but maintained a "Hold." Needham reiterated a Hold post-earnings. Most notably, Sanford C. Bernstein initiated coverage with an "Underperform" rating and a $56 price target — the most bearish call on the Street. Zacks currently ranks CRWV a 4 (Sell), citing expectations of below-average returns.
The debt-to-equity ratio of 4.46, a negative net margin of 22.75%, a negative return on equity of 33.82%, and a current ratio of just 0.46 all underscore the financial leverage and liquidity risks embedded in CoreWeave's aggressive buildout strategy.
---
The Bottom Line
CoreWeave at $79–$80 is a stock that simultaneously offers some of the most compelling AI infrastructure revenue visibility in the public markets — $66.8 billion in contracted backlog, 110% revenue growth, and a blue-chip customer roster — alongside some of the most significant near-term risks on NASDAQ: active securities fraud litigation with today's deadline, meaningful insider selling, a debt-heavy balance sheet, and Q1 margins near zero. The 32-analyst consensus lands at "Moderate Buy" with a $122 target, reflecting the conviction that the long-term infrastructure story outweighs the current turbulence. The path to that target, however, runs directly through today's legal deadline, Q1 earnings execution, and whether the $30–$35 billion capex program stays on schedule.
---
Mentioned tickers: CRWV, CORZ, MELI, GOOG, GOOGL, NVDA
